These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16228920)

  • 1. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
    Jahnke K; Korfel A; Komm J; Bechrakis NE; Stein H; Thiel E; Coupland SE
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):663-9. PubMed ID: 16228920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide or trofosfamide in patients with intraocular lymphoma.
    Jahnke K; Thiel E; Bechrakis NE; Willerding G; Kraemer DF; Fischer L; Korfel A
    J Neurooncol; 2009 Jun; 93(2):213-7. PubMed ID: 19099202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
    Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphoma.
    Jahnke K; Wagner T; Bechrakis NE; Willerding G; Coupland SE; Fischer L; Thiel E; Korfel A
    Ann Oncol; 2005 Dec; 16(12):1974-8. PubMed ID: 16219622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.
    Jahnke K; Bechrakis NE; Coupland SE; Schmittel A; Foerster MH; Fischer L; Thiel E; Korfel A
    Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):771-6. PubMed ID: 15349786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
    Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
    J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
    Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Grimm SA; Pulido JS; Jahnke K; Schiff D; Hall AJ; Shenkier TN; Siegal T; Doolittle ND; Batchelor T; Herrlinger U; Neuwelt EA; Laperriere N; Chamberlain MC; Blay JY; Ferreri AJ; Omuro AM; Thiel E; Abrey LE
    Ann Oncol; 2007 Nov; 18(11):1851-5. PubMed ID: 17804469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
    Soussain C; Hoang-Xuan K; Taillandier L; Fourme E; Choquet S; Witz F; Casasnovas O; Dupriez B; Souleau B; Taksin AL; Gisselbrecht C; Jaccard A; Omuro A; Sanson M; Janvier M; Kolb B; Zini JM; Leblond V;
    J Clin Oncol; 2008 May; 26(15):2512-8. PubMed ID: 18413641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary intraocular lymphoma: A review.
    Choi JY; Kafkala C; Foster CS
    Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.
    Kreher S; Strehlow F; Martus P; Roth P; Hertenstein B; Röth A; Birnbaum T; Griesinger F; Rauch M; Kanz L; Thiel E; Weller M; Korfel A
    Ann Hematol; 2015 Mar; 94(3):409-14. PubMed ID: 25217230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes.
    Fadlelseed H; Rhatigan M; Treacy M; Murphy C; O'Neill J; Kilmartin D; Kennedy S
    Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
    Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
    Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.